Recursion Pharmaceuticals, Inc. · NASDAQ:RXRX
Khan Najat sold 22,408 Recursion Pharmaceuticals, Inc. shares (Form 4)
Traded Sep 8, 2026 · Filed Sep 10, 2026
On Sep 8, 2026, Khan Najat (Director, CEO and President) sold 22,408 Recursion Pharmaceuticals, Inc. shares at US$3.52 for US$78,876 under a trading plan, leaving 2,072,890 shares. Filed Sep 10, 2026 (Form 4).
- Sold
- 22,408 shares
- Price
- US$3.52
- Value
- US$78,876
- Holding after
- 2,072,890 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, CEO and President
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | Class A Common Stock | Sale | 22,408 | US$3.52 | 2,072,890 | Direct |
Source
Related
- Recursion Pharmaceuticals, Inc.
- Khan Najat
- Recursion Pharmaceuticals, Inc. shareholders
- Form 4 · Khan Najat · Aug 18, 2026
- Form 4 · Khan Najat · Jun 5, 2026
- Form 4 · Khan Najat · May 19, 2026
- Form 4 · Borgeson Blake · Oct 7, 2026
- Form 4 · Hershberg Robert · Oct 7, 2026
- Form 4 · Dar Zavain · Oct 2, 2026
- Form 4 · Li Dean Y · Oct 2, 2026
- Form 4 · Taylor Ben R · Sep 16, 2026